March 5, 2020 / 12:22 PM / in 23 days

BRIEF-Fulcrum Therapeutics Reports Qtrly Loss Per Share $0.71

March 5 (Reuters) - Fulcrum Therapeutics Inc:

* FULCRUM THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* FULCRUM THERAPEUTICS INC QTRLY LOSS PER SHARE $0.71

* FULCRUM - EXPECTS EXISTING CASH, CASH EQUIVALENTS TO BE SUFFICIENT TO FUND OPERATING EXPENSES & CAPITAL EXPENDITURE REQUIREMENTS INTO Q3 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below